Literature DB >> 6083458

Interactions between a "calcium channel agonist", Bay K 8644, and calcium antagonists differentiate calcium antagonist subgroups in K+-depolarized smooth muscle.

M Spedding, C Berg.   

Abstract

The proposal that calcium antagonists have different sites of action has been tested by attempting to reverse their inhibitory effects with a dihydropyridine which augments Ca2+ entry into cells, Bay K 8644. Bay K 8644 (1-1000 nmol/l) increased the sensitivity to Ca2+ of K+-depolarized taenia preparations from the guinea-pig caecum. Thus Bay K 8644 augmented established submaximal Ca2+-induced contractions and also shifted cumulative concentration-response curves to Ca2+ to the left, even in the presence of an optimal K+-depolarization. The inhibitory effects of nifedipine (10 nmol/l), verapamil (0.2 mumol/l), diltiazem (1 mumol/l) and diclofurime (1 mumol/l) on Ca2+-induced contractions were reversed by Bay K 8644 (1-1000 nmol/l). In contrast, Bay K 8644 did not reverse the effects of cinnarizine (1 mumol/l), flunarizine (1 mumol/l), fendiline (3 mumol/l), prenylamine (3 mumol/l), pimozide (1 mumol/l), bepridil (3 mumol/l), perhexiline (10 mumol/l) or the calmodulin antagonist W-7 (200 mumol/l). Bay K 8644 (1-100 nmol/l) was less effective at reversing the effects of nisoldipine (10 nmol/l), a slowly dissociating dihydropyridine, than the effects of nifedipine. However, preincubation with Bay K 8644 (1 mumol/l) protected the taenia from the inhibitory effects of nisoldipine (10 nmol/l). These findings are compatible with interactions of nisoldipine and Bay K 8644 at a common site. Taenia preparations incubated with Bay K 8644 (1 mumol/l) were protected from the inhibitory effects of nifedipine (10 nmol/l), nisoldipine (10 nmol/l) and to a lesser extent verapamil (0.2 mumol/l) and diltiazem (1 mumol/l).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6083458     DOI: 10.1007/bf00496109

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  34 in total

1.  Ionic currents in the guinea-pig taenia coli.

Authors:  H Inomata; C Y Kao
Journal:  J Physiol       Date:  1976-02       Impact factor: 5.182

2.  Drugs and the heart. III. Calcium antagonists.

Authors:  L H Opie
Journal:  Lancet       Date:  1980-04-12       Impact factor: 79.321

3.  Differences between the effects of calcium antagonists in the pithed rat preparation.

Authors:  M Spedding
Journal:  J Cardiovasc Pharmacol       Date:  1982 Nov-Dec       Impact factor: 3.105

4.  Changing surface charge with salicylate differentiates between subgroups of calcium-antagonists.

Authors:  M Spedding
Journal:  Br J Pharmacol       Date:  1984-09       Impact factor: 8.739

5.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

6.  Binding of a calcium antagonist, [3H]nitrendipine, to high affinity sites in bovine aortic smooth muscle and canine cardiac membranes.

Authors:  L T Williams; P Tremble
Journal:  J Clin Invest       Date:  1982-07       Impact factor: 14.808

7.  Specific calcium antagonist binding sites in brain.

Authors:  P J Marangos; J Patel; C Miller; A M Martino
Journal:  Life Sci       Date:  1982-10-11       Impact factor: 5.037

8.  Novel 1,4-dihydropyridine (Bay K 8644) facilitates calcium-dependent [3H]noradrenaline release from PC 12 cells.

Authors:  U Albus; E Habermann; D R Ferry; H Glossmann
Journal:  J Neurochem       Date:  1984-04       Impact factor: 5.372

9.  Characterization of binding of the Ca++ channel antagonist, [3H]nitrendipine, to guinea-pig ileal smooth muscle.

Authors:  G T Bolger; P Gengo; R Klockowski; E Luchowski; H Siegel; R A Janis; A M Triggle; D J Triggle
Journal:  J Pharmacol Exp Ther       Date:  1983-05       Impact factor: 4.030

10.  Dihydropyridine receptor in rat brain labeled with [3H]nimodipine.

Authors:  P Bellemann; A Schade; R Towart
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

View more
  23 in total

1.  Inotropic effects of Ca2+ channel agonist and antagonists in neuraminidase-treated left atria of rats.

Authors:  Y Hattori; S Hazama; M Kanno; Y Nakao
Journal:  Br J Pharmacol       Date:  1986-02       Impact factor: 8.739

2.  Effects of Bay K 8644 on contraction of the human isolated bronchus and guinea-pig isolated trachea.

Authors:  C Advenier; E Naline; A Renier
Journal:  Br J Pharmacol       Date:  1986-05       Impact factor: 8.739

3.  Direct activation of Ca2+ channels by palmitoyl carnitine, a putative endogenous ligand.

Authors:  M Spedding; A K Mir
Journal:  Br J Pharmacol       Date:  1987-10       Impact factor: 8.739

4.  Effects of the calcium channel facilitator, CGP 28,392, on different modes of contraction in smooth muscle of rabbit and rat aortae and guinea-pig taenia caeci.

Authors:  H Karaki; H Nagase; H Ozaki; N Urakawa; G B Weiss
Journal:  Br J Pharmacol       Date:  1986-10       Impact factor: 8.739

5.  Effects of calcium channel antagonists and facilitators on beating of primary cultures of embryonic chick heart cells.

Authors:  L Patmore; G P Duncan
Journal:  Br J Pharmacol       Date:  1988-11       Impact factor: 8.739

6.  The effects of calcium antagonists on calcium overload contractures in embryonic chick myocytes induced by ouabain and veratrine.

Authors:  L Patmore; G P Duncan; M Spedding
Journal:  Br J Pharmacol       Date:  1989-05       Impact factor: 8.739

7.  Fendiline inhibits L-type calcium channels in guinea-pig ventricular myocytes: a whole-cell patch-clamp study.

Authors:  O Tripathi; W Schreibmayer; H A Tritthart
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

8.  Kinetic modulation of guinea-pig cardiac L-type calcium channels by fendiline and reversal of the effects of Bay K 8644.

Authors:  W Schreibmayer; O Tripathi; H A Tritthart
Journal:  Br J Pharmacol       Date:  1992-05       Impact factor: 8.739

9.  Inhibitory effects of procaine on contraction and calcium movement in vascular and intestinal smooth muscles.

Authors:  H Y Ahn; H Karaki
Journal:  Br J Pharmacol       Date:  1988-07       Impact factor: 8.739

10.  The calcium channel activator, Bay K 8644, enhances K+-evoked efflux of acetylcholine and noradrenaline from rat brain slices.

Authors:  D N Middlemiss
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-10       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.